Exosomes derived from heat-stressed tumour cells (HS-TEXs), which contain abundant heat shock protein (HSP) 70, strongly induce antitumour immune responses. HSP70-induced interleukin (IL)-6 promotes IL-17 expression and causes rejection of established prostate tumours. However, it remains unclear whether HS-TEXs exhibit antitumour effects by converting regulatory T cells (T regs ) into T helper type 17 (Th17) cells. In this study, we found that compared with TEXs, HS-TEXs were more potent in stimulating secretion of IL-6 from dendritic cells. In vitro, IL-6 blocked tumour cell-derived transforming growth factor beta 1-induced T reg differentiation and promoted Th17 cell differentiation. HS-TEXs exerted strong antitumour effects, converting T regs into Th17 cells with high efficiency, a process that was entirely dependent upon IL-6. Neutralization of IL-17 completely abolished the antitumour effect of TEXs, but only partially inhibited that of HS-TEXs. In addition, we found higher levels of IL-6 and IL-17 in serum from tumour patients treated with hyperthermia, and an increase in Th17 cells and a decrease in T regs was detected in peripheral blood mononuclear cells isolated from these patients after hyperthermia. Therefore, our results demonstrate that HS-TEXs possess a powerful capacity to convert immunosuppressive T regs into Th17 cells via IL-6, which contributes to their potent antitumour effect.
Introduction
Exosomes are small (30-150 nm) membranous vesicles of endocytic origin produced by cells under physiological and pathological conditions. 1 Dendritic cell (DC)-derived exosomes carrying cancer antigens or tumour peptides have been shown to elicit strong immune responses toward cancer cells. 2 Accordingly, exosomes originating from tumours (TEXs) are described as a source of shared antigens for tumour rejection, which can induce potent CD8 + T cell-dependent antitumour effects on syngeneic and allogeneic mouse xenografts. 3 DC-derived exosomes can also promote activation and proliferation of natural killer cells through natural killer group 2D ligands and interleukin (IL)-15 receptor subunit alpha. 4 In addition, exosomes isolated from ascites of T cell lymphoma-bearing mice expressing surface CD24 and heat shock protein (HSP)90 can induce a tumour-specific immune response. 5 Therefore, exosomes can be considered nanoscale cancer vaccines. 6 It has been demonstrated that exosomes exhibit greater antitumour effects when artificially modified. For example, IL-18 and IL-2 gene-modified TEXs are more effective at stimulating antitumour immune responses than unmodified TEXs. 7, 8 In addition, surface anchorage of superantigen staphylococcal enterotoxin A promotes specific TEX-induced antitumour immune responses. 9 Heat-stressed TEXs (HS-TEXs) reportedly contain high levels of HSP70 and are thus very immunogenic; these TEXs are extremely efficient at causing tumour-specific cytotoxic T cell responses. 10 Furthermore, HSP70-enriched HS-TEXs have been shown to induce strong T helper type 1 (Th1) immune responses in vivo, resulting in the elimination of cancer cells in allogeneic hosts. 11 Thus, HS-TEXs are a type of highly efficient and major histocompatibility complex-independent antitumour vaccine.
Th17 cells, a subset of CD4 + T cells, are stimulated by transforming growth factor beta 1 (TGF-b1) and IL-6 cytokines. Mainly secreting proinflammatory cytokines, including IL-17A, IL-17F, IL-21 and IL-23, 12 these cells are involved in eliminating extracellular pathogens. 13 Th17 cells also play a critical role in the progression of autoimmune diseases, 14 and Th17 cells have recently been implicated in antitumour immune responses. Overall, Th17-polarized cells can better mediate the destruction of advanced B16 melanoma compared to Th1-polarized cells, 15 and Th17 cells inhibit melanoma progression by inducing CD8 + cytotoxic T cell responses via IL-2. 16 TGF-b1 induces naive T cells to differentiate into regulatory T cells (T regs ), the main immunosuppressive cells in the tumour niche. However, differentiation switches towards Th17 cells in the presence of IL-6. 17 Indeed, an increase in Th17 cells and a decrease T regs in tumour tissues is observed after alteration of the tumour cytokine environment through over-expression of IL-6 in murine pancreatic tumour cells, directly leading to enhanced survival in a murine model of pancreatic cancer. 18 In the prostate, HSP70 induces IL-6, which triggers CD4-and CD8-dependent progressive autoimmune reactivity associated with IL-17 expression. This autoimmune response can also result in the rejection of established prostate tumours. 19 As described above, HS-TEXs express abundant HSP70, although it remains to be explored whether HS-TEXs exert antitumour effects through HSP70-mediated induction of Th17 cells and inhibition of T regs via IL-6.
In this study, we found HS-TEXs to be more effective at stimulating DCs to secrete IL-6 for converting T regs into Th17 cells in vitro and in vivo. The antitumour effects of both TEXs and HS-TEXs were found to be dependent upon IL-6; moreover, the antitumour effect of TEXs, but not that of HS-TEXs, was completely dependent upon IL-17. We also detected an increase in Th17 cells and a decrease in T regs among peripheral blood mononuclear cells (PBMCs) from patients treated with hyperthermia. Our study suggests that HS-TEXs exert their antitumour effects by converting T regs into Th17 cells. These findings extend our understanding of the antitumour mechanism of HS-TEXs.
Materials and methods

Antibodies and reagents
Primary antibodies against CD63 (MX-49.129.5), tumour susceptibility gene 101 (TSG101) (4A10), apoptosis-linked gene 2-interacting protein X (Alix) (3A9), HSP70 (EPR16892), HSC70 (EP1531Y) were obtained from Abcam (Cambridge, MA). Recombinant mouse and human granulocyte-macrophage colony-stimulating factor (GM-CSF) was purchased from R&D Systems (Minneapolis, MN). Mouse and human IL-4 were purchased from PeproTech (Rocky Hill, NJ). The murine naive CD4 + T cells isolation kit was purchased from Miltenyi Biotec (Bergisch Gladbach, Germany). Phycoerythrin (PE)-conjugated anti-mouse CD4, allophycocyanin (APC)-conjugated anti-mouse IL-17A and APC-conjugated anti-mouse forkhead box protein 3 (FoxP3) antibodies were obtained from BioLegend (San Diego, CA). Mouse and human IL-6 and human IL-17A enzyme-linked immunosorbent assay (ELISA) kits were purchased from eBioscience (San Diego, CA). Anti-CD3 and anti-CD28 antibodies and mouse IL-17-neutralizing monoclonal antibodies (mAb) were obtained from BioXcell (West Lebanon, NH). Dulbecco' modified Eagle's medium (DMEM), fetal bovine serum (FBS) and a bicinchoninic acid (BCA) protein assay kit were obtained from Thermo Fisher Scientific (Waltham, MA).
Mice and cell lines
Female C57BL/6J mice (6-8 weeks old) were purchased from Joint Ventures Sipper BK Experimental Animal Co. (Shanghai, China). The mice were housed in a specific pathogen-free facility. The mouse mouse colon adenocarcinoma (MC38) colon cancer cell line originating from C57BL/6 mice was purchased from American Type Culture Collection (ATCC, Manassas, VA).
Patients and hyperthermia exposure
A total of 12 colorectal cancer patients, aged 40-60 years, with malignant ascites undergoing hyperthermia in the Zhejiang Cancer Hospital, were included into the study. The colorectal cancer patients were treated with hyperthermia in the abdominal region using the NRL-002 double radiofrequency (RF) tumour hyperthermia system. All patients received 60 min of hyperthermia at 39°moni-tored via rectal temperature.
Exosome isolation
The MC38 cell culture supernatant and human malignant ascites from tumour patients were differentially centrifuged at 300 g for 10 min, 1200 g for 20 min and 10 000 g for 30 min at 4°. The supernatants from the final centrifugation step were ultracentrifuged at 100 000 g for 1 hr at 4°. After removing the supernatants, the exosomal pellets were washed in a large volume of ice-cold phosphate-buffered saline (PBS) and centrifuged at 100 000 g for another 1 hr at 4°. The final pellets were resuspended in PBS. All exosomes were free of endotoxin, as confirmed using a Limulus amoebocyte lysate assay (Lonza, Basel, Switzerland) with a detection sensitivity of 0Á1 EU/ml. The amount of exosomal proteins recovered was measured using the BCA assay. Flotation of exosomes on a continuous sucrose gradient was performed as described. 20 Fractions of the gradient (1 ml each) were diluted in 2 ml PBS, centrifuged for 1 hr at 100 000 g.
TEXs were exosomes isolated from 4-hr culture supernatants of MC38 cells, and HS-TEXs were exosomes isolated from the culture supernatant of MC38 cells subjected to heat stress for 1 hr and recovery for 4 hr. Sometimes, MC38 cells were transfected with HSP70 siRNA or negative control (NC) siRNA, as follows, using INTERFERin @ transfection reagent, according to the manufacturer's instructions. The following primers were used: HSP70 siRNA, forward:
0 . Exosomes of malignant ascites from patients before and after hyperthermia are termed as MSExo and HS-MSExo, respectively.
Electron microscopy
Exosomal preparations were stained with osmium tetroxide and then observed with a Philips Tecnai-10 transmission electron microscope operating at 80 kV (Phillips Electronic Instruments, Mahwah, NJ, USA).
Western blotting
A total of 20 lg of exosomes or crude proteins extracted from cell lysates was separated by 12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA). The membranes were blocked with 5% bovine serum albumin (BSA) in Tris-buffered saline/ Tween 20 and then incubated with corresponding primary antibodies overnight at 4°. After incubating with horseradish peroxidase-coupled secondary antibodies for 1 hr, the membranes were scanned using a Tanon 4500 Gel Imaging System (Shanghai, China).
Enzyme-linked immunosorbent assay (ELISA)
MC38 cells or bone marrow-derived DCs (BMDCs) at a density of 5 9 10 5 /ml were stimulated with 5 lg/ml TEXs or HS-TEXs for 6 hr. The levels of mouse IL-6 in the supernatants and human IL-6 and IL-17 in sera from patients were measured by ELISA, according to the manufacturer's instructions.
Generation of DCs
Murine BMDCs were prepared as previously described. 21 Briefly, bone marrow mononuclear cells were prepared from tibia and femur bone marrow suspensions obtained from 6-8-week-old mice via depletion of red cells. The cells were cultured at a density of 2 9 10 6 cells/ml in sixwell plates in RPMI-1640 medium supplemented with 10% FBS, 10 ng/ml recombinant murine GM-CSF and 1 ng/ml mouse IL-4. After 48 hr of culture, non-adherent cells were gently removed by washing; the remaining loosely adherent clusters of cells were cultured for another 48 hr and harvested for subsequent experiments. To generate human DCs, PBMCs from healthy volunteers were isolated by density gradient centrifugation of heparinized blood with LSM â (MP Biomedicals, Solon, OH, USA), resuspended in culture medium and allowed to adhere in six-well plates. After 2 hr at 37°, non-adherent cells were removed, and adherent cells were cultured in 3 ml of medium containing GM-CSF (10 ng/ml) and IL-4 (1 ng/ml). After 3 days, 1Á5 ml of the medium was removed and replaced by the same volume of fresh medium containing GM-CSF and IL-4. DCs were harvested after 7 days of culture, washed and used for subsequent experiments.
Induction of T regs and Th17 cells in vitro
Naive CD4 + T cells were isolated by the murine naive CD4 + T cell isolation kit, according to the manufacturer's instructions. Supernatant was collected from MC38 cells cultured for 24 hr at a density of 5 9 10 5 /ml. Naive CD4 + T cells (2 9 10 6 /ml) and BMDCs (5 9 10 5 /ml) were suspended in the supernatant with 5 lg/ml TEXs or HS-TEXs and added into 96-well plates precoated with 2 lg/ml anti-CD3 and anti-CD28 antibodies. After 3 days, the cells were collected, and the percentage of FoxP3 + CD4 + and IL-17A + CD4 + T cells was analysed by flow cytometry.
Tumour model in vivo
C57BL/6 or IL-6 À/À mice received subcutaneous injections of MC38 cells (1 9 10 6 per mouse) in 0Á1 ml of PBS in the right flank. Seven days after tumour inoculation, 10 lg TEXs or HS-TEXs in 100 ll PBS was intratumourally injected into the tumour nodes every 4 days. Tumour size was measured three times a week with a caliper, and the mice were killed when the tumour volume reached 5 cm 3 . The tumour volume was estimated with the formula: volume = length 9 width 2 /2, and survival status was also evaluated.
Neutralization of IL-17
Seven days after inoculation of MC38 cells into mice, 10 lg TEXs or HS-TEXs in 100 ll PBS was intratumourally injected into the tumour nodes every 4 days. The mice were intraperitoneally injected with 100 lg IL-17-neutralizing antibodies every other day thereafter.
Preparation of tumour-infiltrating lymphocytes (TILs)
Tumours were harvested from mice, minced and digested. Tumour-infiltrating lymphocytes (TILs) were obtained as described previously. 22 
Intracellular cytokine staining
For cytokine analysis by means of intracellular cytokine staining, cells were stimulated with phorbol 12-myristate 13-acetate and ionomycin for 5 hr, with the addition of monensin during the last 4 hr of stimulation. Cells were stained for surface CD4, fixed with 4% neutral-buffered paraformaldehyde, and permeabilized with saponin. The cells were then stained with fluorochrome-conjugated anti-mouse IL-17 and FoxP3 antibodies. The levels of IL-17 and FoxP3 were detected using a fluorescence activated cell sorter (FACS)Calibur flow cytometer (Becton Dickinson, San Jose, CA).
Real-time polymerase chain reaction (PCR)
Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. cDNA was synthesized using a cDNA synthesis kit (Takara, Kusatsu, Shiga, Japan), following the manufacturer's instructions. Real-time PCR was conducted using SYBR Green (Takara). The following PCR conditions were used: 1 cycle at 95°for 30 seconds and then 40 cycles at 95°for 5 seconds and at 60°for 34 seconds. Real-time PCR was performed using an Applied Biosystems 7500 real-time PCR system (Foster City, CA). The following primers were used for real-time PCR: mouse IL-6, forward:
Study approval
The animal studies were approved by the Institutional Animal Care and Use Committee of School of Medicine, Zhejiang University. The collection of human samples was approved by the local ethical committee and the Review Board of the Zhejiang Cancer Hospital. All participants were informed of the usage of the samples, and signed consent forms were obtained.
Statistical analysis
Data are presented as the mean AE standard error of the mean (SEM). Comparisons between two groups were performed using a two-tailed Student's t-test, and comparisons between multiple groups were performed using one-way analysis of variance (ANOVA) and a Tukey-Kramer multiple test with Graphpad PRISM 5 (San Diego, CA). Statistical significance was determined at P < 0Á05.
Results
Isolation and characterization of TEXs and HS-TEXs
We isolated TEXs and HS-TEXs from MC38 colon cancer cells with and without exposure to heat stress (42°, 1 hr), respectively, and then characterized their morphology and components. The TEXs and HS-TEXs isolated are membranous vesicles ranging in size from 50 to 150 nm, as revealed by electron microscopy (Fig. 1a) . These vesicles were found to be positive for several protein markers characteristic of TEXs, such as CD63, tumour susceptibility gene 101 (Tsg101), apoptosis-linked gene 2-interacting protein X (Alix), HSP70 and HSC70. Consistent with previous results, the exosomes from HS-MC38 cells contained a greater abundance of HSP70 and HSC70 proteins (Fig. 1b) . However, to further confirm the quality of the isolated exosomes, we floated them on a sucrose gradient, and we found that Tsg101 and Alix molecules were enriched in the typical exosome fractions with density of 1Á13-1Á19 (Fig. 1c) , suggesting that the isolated HS-TEXs were exosomes. Thus, exosomes were successfully isolated from tumour cell culture supernatants before and after heat stress.
TEX-and HS-TEX-induced IL-6 from bone marrowderived DCs in combination with tumour cell-derived TGF-b1 induces differentiation of Th17 cells in vitro
Tumour tissues are enriched in TGF-b1, which supports polarization of T regs , 23 and we detected high levels of TGF-b1 in the supernatant of MC38 cells (data not shown). Following activation of T cell-receptor signalling with anti-CD3 and anti-CD28 antibodies, naive CD4 + T cells cultured in supernatants from MC38 cells but not fresh culture medium (FCM) were significantly induced to differentiate into T regs . The addition of TEXs or HSTEXs did not affect this process (Fig. 2a) . IL-6 determines the fate of naive T cell differentiation into T regs or Th17 cells, 17 and TEXs have been demonstrated to induce IL-6 production in myeloid cells. 24 Although TEXs or HSTEXs did not induce MC38 cells to produce IL-6 in our study (Fig. 2b) , we found that TEXs induced BMDCs to secrete high levels of IL-6 and that HS-TEXs were more potent in this regard (Fig. 2c) . We also assessed whether BMDCs along with the supernatant from MC38 cells containing TEXs or HS-TEXs can drive differentiation of naive T cells into Th17 cells. As expected, BMDCs alone had no effect on MC38 cell supernatant-mediated differentiation of T regs (Fig. 2d) . However, after the addition of TEXs, differentiation of T regs was largely inhibited, with addition of HS-TEXs completely blocking T reg differentiation (Fig. 2d) . Instead, we detected high numbers of Th17 cells after the addition of TEXs, which was even higher after HS-TEX addition (Fig. 2e) . In the presence of BMDCs from IL-6 À/À mice, neither TEXs nor HSTEXs induced differentiation towards Th17 cells (Fig. 2f) .
These results indicate that TEX-and HS-TEX-induced IL-6 from BMDCs combined with TGF-b1 from tumour cells can induce differentiation toward the Th17 cell subset in vitro. /ml. Naive CD4 + T cells were suspended in the supernatant with 5 lg/ml TEXs or HS-TEXs or fresh culture medium (FCM) and added at a density of 2 9 10 6 /ml to 96-well plates precoated with 2 lg/ml anti-CD3 and anti-CD28 antibodies. After 3 days, the cells were collected, and the percent- published data, intratumoural injection of both TEXs and HS-TEXs significantly inhibited MC38 tumour growth and increased the survival rate of mice with MC38 tumours. Overall, the effects of HS-TEXs were stronger (Fig. 3a) . We detected a moderate increase in IL-6, IL-17 and RAR-related orphan receptor gamma (ROR-ct) mRNA levels and a decrease in the FoxP3 mRNA level in tumour tissues from TEX-treated mice, whereas a substantial increase in IL-6, IL-17 and ROR-ct mRNA levels and a decrease in FoxP3 mRNA were detected in tumour tissues from HS-TEX-treated mice (Fig. 3b) . Furthermore, we found slight or sharp declines in the percentage of T regs among TILs from TEX-treated or HS-TEX-treated mice, respectively (Fig. 3c) . In contrast, the percentage of Th17 cells among TILs from TEX-treated or HS-TEXtreated mice was moderately or markedly elevated, respectively (Fig. 3c) . Altogether, these results suggest that HS-TEXs inhibit T reg differentiation and promote Th17 cell differentiation in tumour tissues with high efficiency.
HS-TEXs converted T regs into Th17 cells in tumour tissues in a HSP70-dependent manner
To confirm the role of HS-TEX-containing HSP70 in converting T regs into Th17 cells, we knocked down HSP70 expression in MC38 cells by HSP70 siRNA before subjecting them to heat-stressed treatment. We found that HSP70 siRNA transfection led to no obvious increase of HSP70 in heat-stressed MC38 cells (Fig. 4a) . Consistent with HSP70 expression in their parent cells, it was HSP70 in exosomes from heat-stressed MC38 cells with NC siRNA transfection (NC siRNA-HS-TEXs), but not with HSP70 siRNA transfection (HSP70 siRNA-HSTEXs), which contained more HSP70 protein when compared with TEXs (Fig. 4a) . Then, we evaluated the ability of these exosomes to induce IL-6 production of BMDCs. We found that although HSP70 siRNA-HS-TEXs still induced higher levels of IL-6 release from BMDCs, this effect was largely impaired when compared with NC siRNA-HS-TEXs (Fig. 4b) . Although slightly better than TEXs, the antitumour effect of HSP70 siRNA-HS-TEXs was weaker than NC siRNA-HS-TEXs (Fig. 4c) . Similarly, the efficiency of HSP70 siRNA-HS-TEXs to convert T regs into Th17 cells was also lower than NC siRNA-HS-TEXs (Fig. 4d) . Altogether, HS-TEXs converted T regs into Th17 cells in tumour tissues is largely HSP70-dependent.
Inhibition of tumour growth by HS-TEXs is completely dependent upon IL-6
To elucidate the role of IL-6 in TEX-and HS-TEXmediated antitumour effects, we established an MC38 tumour model in IL-6 À/À mice. After intratumoural injection of TEXs or HS-TEXs, neither tumour growth inhibition nor enhanced survival was observed (Fig. 5a ).
In addition, treatment with TEXs or HS-TEXs did not alter levels of IL-17, ROR-ct and FoxP3 mRNA in tumour tissues (Fig. 5b) , and we did not observe any difference in the percentage of T regs and Th17 cells among TILs from TEX-or HS-TEX-treated tumours (Fig. 5c) . These results indicate that the TEX-and HS-TEXmediated switch from T regs to Th17 cells in tumour tissues and the inhibition of tumour growth depend upon IL-6.
Inhibition of tumour growth by HS-TEXs is partially dependent upon IL-17
Induction of HSP70-mediated Th17 autoimmunity can be exploited as a strategy for immunotherapy in metastatic prostate cancer. 19 To examine whether HS-TEX-induced Th17 cells contribute to this antitumour effect, we neutralized IL-17 in MC38 tumour-bearing mice by intraperitoneal injection of IL-17-neutralizing antibodies. We found that the ability of HS-TEXs to inhibit MC38 tumour growth and increase the survival rate of mice was markedly impaired, whereas that of TEXs was completely abolished (Fig. 6a) . Given that neutralization of IL-17 did not completely abrogate the antitumour effect of HSTEXs, we hypothesized that the residual antitumour effect may be attributed to the HS-TEX-mediated inhibitory effect on T regs . In fact, we detected a marked or slight decrease in the percentage of T regs among TILs from HS-TEX-treated or TEX-treated mice, respectively (Fig. 6b) . These results demonstrate that Th17 cells play an important role in HS-TEX-mediated antitumour effects.
T regs switch to Th17 cells in patients treated with hyperthermia
Finally, as exosomes from malignant ascites have been shown to possess antitumour effects, we explored whether exosomes from tumour patients treated with hyperthermia can induce Th17 cells and inhibit T regs . 20 We isolated exosomes from malignant ascites from patients before or after hyperthermia treatment (termed MSExo or HSMSExo, respectively) and found that compared with MSExo, HS-MSExo induced significantly higher levels of IL-6 secretion from DCs in vitro (Fig. 7a) . In addition, we detected higher levels of IL-6 and IL-17 in serum from these patients after hyperthermia (Fig. 7b) . We also found that the percentage of Th17 cells increased and that of T regs decreased in PBMCs from patients treated with hyperthermia (Fig. 7c) . These results suggest that T regs switch to Th17 cells in patients after hyperthermia treatment, which might be mediated by exosomes.
Discussion
T regs play a critical role in establishing an immunosuppressive microenvironment in tumours. TGF-b1 is closely linked to the generation of T regs and is enriched in tumour tissues. Therefore, blockage of TGF-b1-mediated T reg differentiation is beneficial for activating antitumour immune responses. In addition to inhibiting T reg differentiation, IL-6 also induces the generation of Th17 cells, which are implicated in antitumour responses. 18 Although neither TEXs nor HS-TEXs induced IL-6 production in tumour cells, they caused robust IL-6 production in BMDCs in vitro. TILs, including DCs and macrophages, 26 can be activated by TEXs and HS-TEXs, thereby becoming a source of IL-6 in the tumour microenvironment. Furthermore, HS-TEXs have been reported to efficiently attract and activate DCs. 25 Therefore, HS-TEXs are more efficient at inducing production of IL-6 in tumour tissues and subsequent inhibition of T reg differentiation and generation of Th17 cells, leading to stronger antitumour effects.
HS-TEXs possess robust antitumour properties. However, their antitumour effect is completely abolished in the absence of IL-6. HSP70-induced IL-6 triggers Th17 cell-like autoimmune reactivity, which may be responsible for the rejection of established prostate tumours. 19 TEXs, especially HS-TEXs, express high levels of HSP70. 10, 27 Thus, HSP70 in TEXs probably contributes to the production of IL-6 in tumours, which can subsequently initiate antitumour immune responses. HS-TEXs are more efficient at activating tumour-specific cytotoxic T lymphocytes. 25 However, our results indicate that the antitumour effect of HS-TEXs is completely dependent upon IL-6. Th17-stimulated CD8⁺ T cells have a distinct role in Th17-induced preventive and therapeutic antitumour immunity, 16 and Th17 cells in tumour tissues participate in recruitment of tumour-specific cytotoxic T lymphocytes. 28 Therefore, HS-TEX-activated tumour-specific cytotoxic T lymphocytes and their antitumour effects probably require the assistance of Th17 cells. Although the antitumour effect of TEXs and HS-TEXs depends upon IL-6, neutralization of IL-17 abolished the antitumour effect of TEXs but only partially inhibited that of HS-TEXs. T regs can be used to predict the clinical outcomes of tumour patients. 29 Both TEXs and HS-TEXs can inhibit the percentage of FoxP3 + T regs in tumours; however, only HS-TEXs decrease the percentage of FoxP3 + T regs in tumour tissues, which probably contributes to the antitumour effect of HS-TEXs in the absence of IL-17.
Following hyperthermia treatment, we detected higher levels of IL-6 and IL-17 in serum from tumour patients. In addition, we found an increase in Th17 cells and a decrease in T regs among tumour patient PBMCs, although we could not confirm whether exosomes are involved in this process. Nonetheless, we found that HS-MSExo stimulated BMDCs to secrete higher levels of IL-6 compared to MSExo, which is critical for T reg switching towards Th17 cells. 18 As heatstressed tumour cells can release more exosomes containing high levels of HSP70, 25 HS-MSExo may participate in increasing the antitumour immunity of the host.
In summary, our results reveal that HS-TEXs are very effective at converting immunosuppressive T regs into Th17 cells and that IL-6 plays a critical role in this process. IL-6 determines the antitumour effect of HS-TEXs. If HS-TEXs are used in the clinic as antitumour vaccines in the future, their ability to convert T regs into Th17 cells should be seriously considered.
